The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation
References (12)
- et al.
Long-term effects of MPA on human progeny: intellectual development
Contraception
(1988) - et al.
Long-term follow-up of children breast-fed by mothers receiving depo-medroxyprogesterone actetate
Contraception
(1984) - et al.
In-utero exposure to steroid contraceptives and outcome of pregnancy
Amer J Epidemiol
(1991) - et al.
In-utero exposure to steroid contraceptives and survival during infancy
Amer J Epidemiol
(1991) Prenatal exposure of human fetuses to synthetic progestin and estrogen affects personality
Nature
(1977)The Effect of Female Sex Hormones on Fetal Development and Infant Health
Cited by (53)
Medroxyprogesterone acetate drives M2 macrophage differentiation toward a phenotype of decidual macrophage
2017, Molecular and Cellular EndocrinologyDoes using the “pregnancy checklist” delay safe initiation of contraception?
2017, ContraceptionProgestogen-only contraceptive use among breastfeeding women: a systematic review
2016, ContraceptionCitation Excerpt :The literature search yielded 848 articles; 771 were excluded on title and abstract review and 28 were excluded after full-text review, leaving 49 reports meeting inclusion criteria. Since this review was last updated in 2008 [13], four new randomized controlled trials (RCTs) [20–23] and five new observational studies were published [16,24–27], and an additional five observational studies that were not included in the 2008 review were identified [28–32], for a total of eight reports of RCTs and 41 reports of nonrandomized clinical trials or observational studies for review (Table 1). These 49 articles reported on 47 different studies investigating the use of POCs in breastfeeding women and reported clinically relevant outcomes of infant growth, health or breastfeeding performance.
Drugs and Environmental Agents in Pregnancy and Lactation: Teratology, Epidemiology
2016, Obstetrics: Normal and Problem PregnanciesCanadian Contraception Consensus (part 3 of 4): Chapter 8 - Progestin-only contraception
2016, Journal of Obstetrics and Gynaecology CanadaCitation Excerpt :Un test de grossesse devrait être à nouveau mené de trois à quatre semaines plus tard. L’AMPR n’exerce pas d’effets tératogènes s’il est administré par mégarde en présence d’une grossesse188,189. Peu de médicaments interagissent avec l’AMPR.